Digital health has a decision-making problem: the technology is moving faster than procurement cycles, and health system executives rarely have the bandwidth to evaluate vendors, benchmark competitors, and align on strategy simultaneously. ViVE 2027, co-created by HLTH and CHIME, running March 14-17 in Nashville, TN, is built specifically to solve that problem, and with 7,000+ attendees and 2,000+ C-level executives expected, this edition carries more weight than most.
Why Digital Health Timing Makes ViVE 2027 Critical
Three dynamics are converging in healthcare IT right now that make this year's event particularly consequential.
First, AI integration in clinical workflows has moved from pilot programs to procurement decisions. Health systems that spent 2025 and 2026 running proof-of-concept trials are now writing contracts, and the vendors who established relationships early are winning those deals.
Second, interoperability mandates continue to reshape how health systems evaluate technology partners. The ability to demonstrate clean data exchange across platforms is no longer a differentiator; it's a baseline requirement. Vendors who can't prove it on the floor are being removed from shortlists before the conversation starts.
Third, payer-provider alignment on digital tools is tightening. The presence of both payer organizations and health system executives at the same event is not incidental. It reflects a genuine shift in how digital health solutions are being evaluated: across the full care and reimbursement cycle, not just within a single organization's walls.
These three pressures are why ViVE exists, and why the Nashville gathering in March matters beyond the networking calendar.
The Concentration of Power ViVE 2027 Creates
The argument for attending any trade show comes down to density. What takes twelve months of outbound sales calls, conference calls, and regional roadshows can happen in three days when the right people are in the same building.
At ViVE 2027, that density is unusually high. The 2,000+ C-level decision-makers in attendance include CIOs, CTOs, and CMIOs from health systems and payer organizations, the exact titles that sign off on enterprise digital health contracts. For technology vendors across AI and machine learning, healthcare interoperability, and health security software, this is not a lead generation event in the traditional sense. It is a qualification event. The buyers are already there, already in evaluation mode, and already comparing solutions.
For health system executives on the buyer side, the 600+ sponsors and exhibitors create something that no vendor briefing cycle can replicate: side-by-side competitive benchmarking in a single afternoon. A CMIO can walk from an AI-powered diagnostic platform to a competing interoperability solution to a cybersecurity vendor and have three substantive conversations before lunch. That compression of evaluation time has real value when IT procurement timelines are measured in quarters.
The curated 1:1 matchmaking programs built into ViVE's structure make this even more precise. Attendees are not wandering a floor hoping to find relevant partners. They are being connected to pre-qualified counterparts, which means the conversations that happen here start further along the trust curve than a cold introduction at a generic healthcare conference.
What Actually Gets Decided at ViVE
Vendor shortlists get built here. A health system CIO who walks into ViVE 2027 with three vendors already on their radar will likely leave with a clearer ranking, and possibly a fourth or fifth option they hadn't considered. The exhibitor profile at ViVE spans digital health technology, healthcare consulting services, medical devices, and diagnostic technology, which means the evaluation scope for buyers is genuinely broad.
Partnerships between solution providers also get initiated on this floor. A healthcare IT vendor and a consulting firm that have been circling each other through LinkedIn introductions will often close the gap at an event like this, where a twenty-minute conversation in a booth can accomplish what three months of email threads cannot.
For investors and startup founders in the room, ViVE is where funding conversations get context. A digital health startup presenting to an investor who has just spent two days watching health system executives react to competing products has a very different conversation than one pitching cold. The shared context of the floor changes the quality of those discussions.
And for government policymakers and health IT security professionals in attendance, ViVE is one of the few environments where regulatory and operational perspectives meet technology vendors directly. That proximity shapes product roadmaps and procurement criteria in ways that don't happen through formal comment processes.
For exhibitors managing a high volume of C-suite conversations across three days, contact capture becomes a real operational challenge. The Habsy App lets you record a voice note on the spot after each conversation, tagging intent level and follow-up priority, so your post-show outreach reflects what was actually discussed rather than a stack of business cards with no context attached.
What's at Stake If You Skip ViVE 2027
For vendors not present in Nashville, the practical consequence is straightforward: competitors who are there will be on shortlists that you are not. Health system executives finalizing vendor evaluations in Q2 2027 will be working from relationships and impressions formed at ViVE. For visitors who skip it, the cost is slower strategy cycles and procurement decisions made with less competitive context than peers who attended.
Track the full exhibitor and speaker lineup at ViVE 2027 on TradeShowIntel as the March dates approach.
Prefer TradeShowIntel in your Google results
Add us as a preferred source and our event coverage shows up higher when you search on Google.
Add us as a preferred source on Google